| Date | Price Target | Rating | Analyst |
|---|---|---|---|
| 4/23/2024 | $12.60 | Buy | HSBC Securities |
| 4/16/2024 | $16.00 | Overweight | JP Morgan |
| 4/16/2024 | $14.00 | Overweight | Morgan Stanley |
Auna S.A. (NYSE:AUNA) ("Auna" or "the Company"), a leading Latin American healthcare services and plan provider with operations in Mexico, Peru and Colombia, announced today the reporting dates for its First Quarter 2025 financial results. Earnings Release Tuesday, May 20, 2025 Time: After Market Close Conference Call Wednesday, May 21, 2025 Time: 8:00 a.m. ET Quiet Period Monday, April 28 through Tuesday, May 20, 2025 To participate, please dial +1 888 596 4144 (Toll-Free) +1 646 968 2525 (International) Entry Passcode: 3884034 Webcast: click here About Auna Auna is a leading horizontally and vertically integrated healthcare platform in Latin America with operations in Mexic
Auna S.A. ("Auna" or the "Company") (NYSE:AUNA), a Latin American healthcare company with operations in Mexico, Peru and Colombia, announced today the filing of its Annual Report on Form 20-F for the fiscal year ended December 31, 2024, with the Securities and Exchange Commission (the "SEC") on April 10, 2025. Auna's Annual Report on Form 20-F can be accessed by visiting either the SEC's website at www.sec.gov or the "Financial Info" section of the Company's Investor Relations website at www.aunainvestors.com. In addition, shareholders may receive a hard copy of the Company's audited financial statements, or its complete 2024 Form 20-F including audited financial statements, free of charge
Adjusted EBITDA increases 20.1% FXN in FY 2024 and Net Operating Cash Flows increase 15% YoY Auna (NYSE:AUNA) ("Auna" or the "Company"), a leading healthcare platform in Latin America with operations in Mexico, Peru, and Colombia, today announced financial results for the fourth quarter ended December 31, 2024 ("fourth quarter 2024" or "4Q24") and full year ended 2024 ("full-year 2024" or "FY24"). Financial results are expressed in Peruvian Soles ("S/" or PEN") and are presented in accordance with International Financial Reporting Standards ("IFRS"), unless otherwise noted. 4Q24 Consolidated Highlights Consolidated Revenue increased 4% YoY to S/1,063 million, or +11% FXN Adjusted EBIT
Auna S.A. (NYSE:AUNA) ("Auna" or the "Company"), a Latin American healthcare company with operations in Mexico, Peru, and Colombia, announced today the signing of an exclusive five-year agreement with a physician group practicing at Organización Para Cuidado Integral en Oncología, S.A. de C.V. known as Opción Oncología, the premier oncology ambulatory clinic in Monterrey. This strategic partnership strengthens Auna's commitment to becoming the leading oncology provider in Mexico and marks a significant step in consolidating oncology services within Auna Mexico. As part of this agreement, eight highly regarded physicians – six oncologists and two radiation oncologists – will join Auna. Toda
Auna S.A. (NYSE:AUNA) ("Auna" or "the Company"), a leading Latin American healthcare services and plan provider with operations in Mexico, Peru and Colombia, announced today the reporting dates for its Fourth Quarter and Full-Year 2024 financial results. Earnings Release Monday, March 10, 2025 Time: After Market Close Conference Call Tuesday, March 11, 2025 Time: 8:00 a.m. ET Quiet Period Monday, February 17 through Monday, March 10, 2025 To participate, please dial +1 888 596 4144 (Toll-Free) +1 646 968 2525 (International) Entry Passcode: 3884034 Webcast: click here About Auna Auna is a leading horizontally and vertically integrated healthcare platform in Lat
Auna S.A. (NYSE:AUNA) ("Auna" or the "Company"), a Latin American healthcare company with operations in Mexico, Peru and Colombia, announced today the closing of a private placement of USD 57,826,321 aggregate principal amount of its 10.000% Senior Secured Notes due 2029 (the "Additional 2029 Notes"). The proceeds from the Additional 2029 Notes were used to fully redeem the USD 57,826,321 in aggregate principal amount outstanding of its 6.500% Senior Secured Notes due 2025 at a redemption price of 101.625% of the principal amount thereof plus interest to, but excluding, the redemption date. The Additional 2029 Notes were issued as additional notes under the indenture governing the outstan
Auna S.A. (NYSE:AUNA) ("Auna" or the "Company"), a leading Latin American healthcare company operating in Mexico, Peru, and Colombia, today announced the appointment of two new independent directors, Teresa Gutierrez and Guadalupe Phillips, to its Board of Directors, effective January 1, 2025. Ms. Gutierrez is responsible for Tesla in Mexico. Prior to that, she held positions at Rappi, Mattel, Nestle, McKinsey, and Procter and Gamble. She serves on the boards of several public and private companies, including Traxion, DIRI, Vetalia, and Timser. Ms. Phillips is the Chief Executive Officer of ICA, a prominent construction and infrastructure company in Mexico after a long career holding se
Adjusted EBITDA increases 23% YoY FXN, maintaining strong growth Leverage ratio decreases 0.4x to 3.7x Auna (NYSE:AUNA) ("Auna" or the "Company"), a leading healthcare platform in Latin America with operations in Mexico, Peru and Colombia, today announced unaudited financial results for the third quarter ended September 30, 2024 ("third quarter 2024" or "3Q24"). Financial results are expressed in Peruvian Soles ("S/" or PEN") and are presented in accordance with International Financial Reporting Standards ("IFRS"), unless otherwise noted. 3Q24 Consolidated Highlights Consolidated Revenue increased 11% YoY to S/1,127 million Adjusted EBITDA increased 18% YoY to S/250 million, or
Auna S.A. (NYSE:AUNA) ("Auna" or "the Company"), a leading Latin American healthcare services and plan provider with operations in Mexico, Peru and Colombia, announced today the reporting dates for its Third Quarter 2024 financial results. Earnings Release Tuesday, November 19, 2024 Time: After Market Close Conference Call Wednesday, November 20, 2024 Time: 8:00 a.m. ET Quiet Period Monday, November 11 through Tuesday, November 19, 2024 To participate, please dial +1 888 596 4144 (Toll-Free) +1 646 968 2525 (International) Entry Passcode: 3884034 Webcast: click here About Auna Auna is a leading healthcare platform in Latin American healthcare company with operations in Mexico
Auna S.A. (NYSE:AUNA) ("Auna" or the "Company"), a Latin American healthcare company with operations in Mexico, Peru and Colombia, announced today the appointment of Laurent "Lorenzo" Massart as Executive Vice President, Strategy and Equity Capital Markets to its executive team. "We are thrilled to welcome Lorenzo to the Auna team. With over 25 years of experience in consulting and investment banking, he brings a wealth of knowledge and expertise to this newly created role. He has been a key and trusted advisor in our strategic endeavors and has worked closely with me and Auna for the last three years, playing an integral part of our journey into Mexico and on becoming a public company,"
Auna S.A. (NYSE:AUNA) ("Auna" or "the Company"), a leading Latin American healthcare services and plan provider with operations in Mexico, Peru and Colombia, announced today the reporting dates for its First Quarter 2025 financial results. Earnings Release Tuesday, May 20, 2025 Time: After Market Close Conference Call Wednesday, May 21, 2025 Time: 8:00 a.m. ET Quiet Period Monday, April 28 through Tuesday, May 20, 2025 To participate, please dial +1 888 596 4144 (Toll-Free) +1 646 968 2525 (International) Entry Passcode: 3884034 Webcast: click here About Auna Auna is a leading horizontally and vertically integrated healthcare platform in Latin America with operations in Mexic
Adjusted EBITDA increases 20.1% FXN in FY 2024 and Net Operating Cash Flows increase 15% YoY Auna (NYSE:AUNA) ("Auna" or the "Company"), a leading healthcare platform in Latin America with operations in Mexico, Peru, and Colombia, today announced financial results for the fourth quarter ended December 31, 2024 ("fourth quarter 2024" or "4Q24") and full year ended 2024 ("full-year 2024" or "FY24"). Financial results are expressed in Peruvian Soles ("S/" or PEN") and are presented in accordance with International Financial Reporting Standards ("IFRS"), unless otherwise noted. 4Q24 Consolidated Highlights Consolidated Revenue increased 4% YoY to S/1,063 million, or +11% FXN Adjusted EBIT
Auna S.A. (NYSE:AUNA) ("Auna" or "the Company"), a leading Latin American healthcare services and plan provider with operations in Mexico, Peru and Colombia, announced today the reporting dates for its Fourth Quarter and Full-Year 2024 financial results. Earnings Release Monday, March 10, 2025 Time: After Market Close Conference Call Tuesday, March 11, 2025 Time: 8:00 a.m. ET Quiet Period Monday, February 17 through Monday, March 10, 2025 To participate, please dial +1 888 596 4144 (Toll-Free) +1 646 968 2525 (International) Entry Passcode: 3884034 Webcast: click here About Auna Auna is a leading horizontally and vertically integrated healthcare platform in Lat
Adjusted EBITDA increases 23% YoY FXN, maintaining strong growth Leverage ratio decreases 0.4x to 3.7x Auna (NYSE:AUNA) ("Auna" or the "Company"), a leading healthcare platform in Latin America with operations in Mexico, Peru and Colombia, today announced unaudited financial results for the third quarter ended September 30, 2024 ("third quarter 2024" or "3Q24"). Financial results are expressed in Peruvian Soles ("S/" or PEN") and are presented in accordance with International Financial Reporting Standards ("IFRS"), unless otherwise noted. 3Q24 Consolidated Highlights Consolidated Revenue increased 11% YoY to S/1,127 million Adjusted EBITDA increased 18% YoY to S/250 million, or
Auna S.A. (NYSE:AUNA) ("Auna" or "the Company"), a leading Latin American healthcare services and plan provider with operations in Mexico, Peru and Colombia, announced today the reporting dates for its Third Quarter 2024 financial results. Earnings Release Tuesday, November 19, 2024 Time: After Market Close Conference Call Wednesday, November 20, 2024 Time: 8:00 a.m. ET Quiet Period Monday, November 11 through Tuesday, November 19, 2024 To participate, please dial +1 888 596 4144 (Toll-Free) +1 646 968 2525 (International) Entry Passcode: 3884034 Webcast: click here About Auna Auna is a leading healthcare platform in Latin American healthcare company with operations in Mexico
Adjusted EBITDA increases 31% YoY, consolidating strong results OncoMexico launched in Monterrey Auna (NYSE:AUNA) ("Auna" or the "Company"), a leading healthcare platform in Latin America with operations in Mexico, Colombia and Peru, today announced unaudited financial results for the second quarter ended June 30, 2024 ("second quarter 2024" or "2Q24"). Financial results are expressed in Peruvian Soles ("S/" or PEN") and are presented in accordance with International Financial Reporting Standards ("IFRS"), unless otherwise noted. 2Q24 Consolidated Highlights Consolidated Revenue increased 18% YoY to S/1,120 million Operating profit increased 34% YoY to S/183 million Adjusted
Auna S.A. (NYSE:AUNA) ("Auna" or "the Company"), a leading Latin American healthcare services and plan provider with operations in Mexico, Peru and Colombia, announced today the reporting dates for its Second Quarter 2024 financial results. Earnings Release Wednesday, August 21, 2024 Time: After Market Close Conference Call Wednesday, August 21, 2024 Time: 5:00 p.m. ET Quiet Period Friday, August 2 through Wednesday, August 21, 2024 To participate, please dial +1 888 596 4144 (Toll-Free) +1 646 968 2525 (International) Entry Passcode: 3884034 Webcast: click here About Auna Auna is a Latin American healthcare company with operations in Mexico, Peru and Colombia,
Revenue increases 20% YoY to S/1,076 million, with operating profit increasing 26% to S/182 million Adjusted EBITDA margin of 20.4% in Peruvian operations Auna (NYSE:AUNA) ("Auna" or the "Company"), one of the largest and most recognized company in Latin America's healthcare industry with operations in Mexico, Colombia and Peru, today announced unaudited financial results for the three months ended March 31, 2024 ("first quarter 2024" or "1Q24"). Financial results are expressed in Peruvian Soles ("S/" or PEN") and are presented in accordance with International Financial Reporting Standards ("IFRS"), unless otherwise noted. Figures in US dollars (US$ or USD) for 1Q24 are presented for
Auna S.A. (NYSE:AUNA) ("Auna" or "the Company"), a leading Latin American healthcare services and plan provider with operations in Mexico, Peru and Colombia, announced today the reporting dates for its First Quarter 2024 financial results. Earnings Release Wednesday, May 22, 2024 Time: After Market Close Conference Call Wednesday, May 22, 2024 Time: 5:00 p.m. ET Quiet Period Wednesday, May 8 through Wednesday, May 22, 2024 To participate, please dial +1 888 596 4144 (Toll-Free) +1 646 968 2525 (International) Entry Passcode: 3884034 Webcast: click here About Auna Auna is a Latin American healthcare company with operations in Mexico, Peru and Colombia, prioritizin
F-3/A - AUNA S.A. (0001799207) (Filer)
F-3 - AUNA S.A. (0001799207) (Filer)
6-K - AUNA S.A. (0001799207) (Filer)
20-F - AUNA S.A. (0001799207) (Filer)
SCHEDULE 13G/A - AUNA S.A. (0001799207) (Subject)
6-K - AUNA S.A. (0001799207) (Filer)
6-K - AUNA S.A. (0001799207) (Filer)
SCHEDULE 13G - AUNA S.A. (0001799207) (Subject)
SCHEDULE 13D/A - AUNA S.A. (0001799207) (Subject)
SCHEDULE 13G/A - AUNA S.A. (0001799207) (Subject)
HSBC Securities initiated coverage of Auna S.A. with a rating of Buy and set a new price target of $12.60
JP Morgan initiated coverage of Auna S.A. with a rating of Overweight and set a new price target of $16.00
Morgan Stanley initiated coverage of Auna S.A. with a rating of Overweight and set a new price target of $14.00
Auna S.A. (NYSE:AUNA) ("Auna" or the "Company"), a Latin American healthcare company with operations in Mexico, Peru, and Colombia, announced today the signing of an exclusive five-year agreement with a physician group practicing at Organización Para Cuidado Integral en Oncología, S.A. de C.V. known as Opción Oncología, the premier oncology ambulatory clinic in Monterrey. This strategic partnership strengthens Auna's commitment to becoming the leading oncology provider in Mexico and marks a significant step in consolidating oncology services within Auna Mexico. As part of this agreement, eight highly regarded physicians – six oncologists and two radiation oncologists – will join Auna. Toda
Auna S.A. (NYSE:AUNA) ("Auna" or the "Company"), a leading Latin American healthcare company operating in Mexico, Peru, and Colombia, today announced the appointment of two new independent directors, Teresa Gutierrez and Guadalupe Phillips, to its Board of Directors, effective January 1, 2025. Ms. Gutierrez is responsible for Tesla in Mexico. Prior to that, she held positions at Rappi, Mattel, Nestle, McKinsey, and Procter and Gamble. She serves on the boards of several public and private companies, including Traxion, DIRI, Vetalia, and Timser. Ms. Phillips is the Chief Executive Officer of ICA, a prominent construction and infrastructure company in Mexico after a long career holding se
Auna S.A. (NYSE:AUNA) ("Auna" or the "Company"), a Latin American healthcare company with operations in Mexico, Peru and Colombia, announced today the appointment of Laurent "Lorenzo" Massart as Executive Vice President, Strategy and Equity Capital Markets to its executive team. "We are thrilled to welcome Lorenzo to the Auna team. With over 25 years of experience in consulting and investment banking, he brings a wealth of knowledge and expertise to this newly created role. He has been a key and trusted advisor in our strategic endeavors and has worked closely with me and Auna for the last three years, playing an integral part of our journey into Mexico and on becoming a public company,"
SC 13G - AUNA S.A. (0001799207) (Subject)
SC 13G/A - AUNA S.A. (0001799207) (Subject)
SC 13G - AUNA S.A. (0001799207) (Subject)
SC 13G/A - AUNA S.A. (0001799207) (Subject)
SC 13D/A - AUNA S.A. (0001799207) (Subject)
SC 13D - AUNA S.A. (0001799207) (Subject)
SC 13D - AUNA S.A. (0001799207) (Subject)
SC 13G/A - AUNA S.A. (0001799207) (Subject)